USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Regis Chemical Company
Address:
8210 Austin Avenue
Morton Grove, IL 60053
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $149,994.00 3
SBIR Phase II $928,004.00 2

Award List:

HPLC SERUM ANALYSES WITHOUT PRIOR PROTEIN REMOVAL

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
John A Perry , Principal Investigator
Abstract:
N/a

HPLC SERUM ANALYSES WITHOUT PRIOR PROTEIN REMOVAL

Award Year / Program / Phase:
1988 / SBIR / Phase II
Award Amount:
$429,000.00
Agency:
HHS
Principal Investigator:
John A Perry , Principal Investigator
Abstract:
Drugs now determined in serum-hundreds of thousands of samples per year in the united states alone-by high-pressureliquid chromatography (hplc). protein must first be removedfrom the serum, otherwise the hplc columns are quickly ruined. internal-surface reversed-phase (isrp) hplc columnsafford such… More

IMMOBILIZED ARTIFICIAL MEMBRANE (IAM) CHROMATOGRAPHY

Award Year / Program / Phase:
1992 / SBIR / Phase I
Award Amount:
$49,994.00
Agency:
HHS
Principal Investigator:
Louis J Glunz
Abstract:
N/a

IMMOBILIZED ARTIFICIAL MEMBRANE (IAM) CHROMATOGRAPHY

Award Year / Program / Phase:
1993 / SBIR / Phase II
Award Amount:
$499,004.00
Agency:
HHS
Principal Investigator:
Louis J Glunz
Abstract:
Membrane protein studies are severely limited by lack of efficient methods for their purification. iam surfaces have recently been discovered and are extremely effective at purifying functional membranes proteins. since iam surfaces are prepared by covalently bonding membrane-forming-lipids to… More

Enantioselective Catalytic Methods for Drug Synthesis

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Christopher J. Welch
Abstract:
A new family of enantioselective dirhodiumn(II) catalysts have been developed by Professor Michael P. Doyle at Trinity University using a rational approach employing molecular modeling and molecular orbital calculations. These catalysts show an extraordinary ability to enantioselectively catalyze a… More